{"id":"W2905794790","doi":"10.1007/s13555-018-0279-5","title":"Clinical Goals and Barriers to Effective Psoriasis Care","year":2018,"lang":"en","type":"article","venue":"Dermatology and Therapy","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":93,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Université de Sherbrooke; Dermatrials Research; Probity Medical Research","funders":"Cilag; Allergan; Medac; Astellas Pharma; Glenmark Pharmaceuticals; National Psoriasis Foundation; Pfizer; Incyte; Dermira; Sun Pharma; Regeneron Pharmaceuticals; University of Connecticut; Eli Lilly and Company; Cardiff University; Celgene; LEO Pharma; Ortho Dermatologics; Gilead Sciences; Sanofi; GlaxoSmithKline; Galderma; Bristol-Myers Squibb; Meiji Seika Pharma; Coherus Biosciences; UCB Pharma; Valeant Pharmaceuticals International; Amgen","keywords":"Psoriasis; Pace; Medicine; Disease; Intensive care medicine; Alternative medicine; Business; Family medicine; Dermatology; Pathology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001295094,0.0001840076,0.0003798307,0.00008282472,0.000362128,0.00001039427,0.00008869925,0.0003803293,0.0002177764],"category_scores_gemma":[0.00006489029,0.0001451439,0.00006374843,0.0000808649,0.0004894526,0.00004472068,0.00004482866,0.0001143648,0.0002367664],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000006723792,"about_ca_system_score_gemma":0.0000294615,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000191312,"about_ca_topic_score_gemma":0.00002797271,"domain_scores_codex":[0.9986802,0.0004578627,0.0002053293,0.0003667416,0.00001525006,0.0002746438],"domain_scores_gemma":[0.9993028,0.0002996363,0.00004999853,0.0001899234,0.00006162128,0.00009603569],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.001128184,0.00004106299,0.4917783,0.000009240335,0.0006515545,0.00002281098,0.004212567,1.887052e-8,0.00399534,0.0007721185,0.001789139,0.4955997],"study_design_scores_gemma":[0.01024244,0.00178636,0.524533,0.00003228373,0.0001911232,0.0007191413,0.001860647,9.033615e-7,0.1213147,0.0008129285,0.3379486,0.0005578791],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9802159,0.01700472,0.00003011256,0.0004429519,0.001010955,0.0003717656,0.00002653673,0.00005657496,0.0008404885],"genre_scores_gemma":[0.9962238,0.00181025,0.00009241926,0.001556043,0.00008643571,0.00006973917,0.00002229426,0.00001285672,0.0001261749],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4950418,"threshold_uncertainty_score":0.5918797,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01353686459235835,"score_gpt":0.2924971744397164,"score_spread":0.278960309847358,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}